BALYASNY ASSET MANAGEMENT L.P. - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$9,991,265
+2698.7%
1,380,009
+6929.0%
0.02%
+1900.0%
Q3 2022$357,000
-78.8%
19,633
-14.1%
0.00%
-80.0%
Q1 2022$1,685,000
-78.3%
22,867
-39.0%
0.01%
-84.4%
Q3 2021$7,765,000
-56.8%
37,457
-55.8%
0.03%
-62.4%
Q2 2021$17,986,000
+112.7%
84,716
+81.6%
0.08%
+102.4%
Q1 2021$8,457,000
+195.1%
46,644
+81.5%
0.04%
+162.5%
Q4 2020$2,866,00025,6990.02%
Other shareholders
NOVAVAX INC shareholders Q4 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 132,500$2,414,0000.77%
HAP Trading, LLC 130,000$10,673,0000.71%
Mendel Capital Management LLC 23,835$434,0000.51%
Faithward Advisors, LLC 115,912$2,109,0000.50%
Rock Springs Capital Management LP 599,300$10,907,0000.28%
SECTOR GAMMA AS 56,735$1,033,0000.27%
Quantitative Investment Management, LLC 83,072$1,511,0000.25%
LMR Partners LLP 396,100$7,209,0000.13%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1,333,706$24,273,0000.13%
TSP Capital Management Group, LLC 16,025$292,0000.12%
View complete list of NOVAVAX INC shareholders